![Tom Jobling](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tom Jobling
Direttore/Membro del Consiglio presso CLEO DIAGNOSTICS LTD
Profilo
Tom W Jobling is the founder of Ovarian Cancer Research Foundation, Inc. founded in 1999, where he holds the title of Member-Pelvic Surgeons.
He is currently a Non-Executive Director & Lead Medical Advisor at CLEO Diagnostics Ltd.
since 2022, and also holds the position of Head-Gynecological Oncology at Monash Health, and is a Member of Australia New Zealand Gynaecological Oncology Group and The Australian Society of Gynaecologic Oncology Co. Dr. Jobling obtained his undergraduate degree from Monash University in 1980.
Posizioni attive di Tom Jobling
Società | Posizione | Inizio |
---|---|---|
CLEO DIAGNOSTICS LTD | Direttore/Membro del Consiglio | 21/12/2022 |
Monash Health
![]() Monash Health Hospital/Nursing ManagementHealth Services Monash Health operates as a cardiac hospital. The private company is based in Springvale, Australia. | Corporate Officer/Principal | - |
Ovarian Cancer Research Foundation, Inc. | Fondatore | 01/01/1999 |
Australia New Zealand Gynaecological Oncology Group | Corporate Officer/Principal | - |
The Australian Society of Gynaecologic Oncology Co. | Corporate Officer/Principal | - |
Formazione di Tom Jobling
Monash University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CLEO DIAGNOSTICS LTD | Health Technology |
Aziende private | 4 |
---|---|
Monash Health
![]() Monash Health Hospital/Nursing ManagementHealth Services Monash Health operates as a cardiac hospital. The private company is based in Springvale, Australia. | Health Services |
Ovarian Cancer Research Foundation, Inc. | |
Australia New Zealand Gynaecological Oncology Group | |
The Australian Society of Gynaecologic Oncology Co. |
- Borsa valori
- Insiders
- Tom Jobling